Abstract:Machine learning models are employed to enhance the speed and provide novel insights in drug discovery due to their demonstrated effectiveness in predicting properties of small molecules like pKa, solubility, and binding affinity. These approaches accelerate drug discovery by helping researchers efficiently identify, prioritize, and optimize compounds. Nonetheless, when investigating properties that depend on the interaction between a ligand and its corresponding protein, a compelling need arises to incorporate the protein counterpart information within the models. Recently, graph neural networks (GNNs) have been developed to incorporate 3D structural information to improve our understanding of the underlying protein-ligand interactions. However, incorporating 3D information into GNNs is not always straightforward. To address the challenge, we introduce a model called InterGraph, which models the protein-ligand interaction as topological multigraphs. By leveraging a topological representation, InterGraph offers a comprehensive approach to a graph representation of the intricate spatial organization and connectivity patterns within protein-ligand systems. We introduce interaction spheres that assign varying edge densities, capturing the proximity-based influence of interactions. This approach enables us to capture the characteristics of the interaction network, filtering out the ones that are beyond 9 Å from the ligand since they are not considered relevant or established. Finally, we trained the model using a ligand binding dataset from PDBbind and tested it on a hold-out test set, achieving an RMSE value of 1.34. Our findings have demonstrated the power of the multigraph to encode the importance of close interactions, a factor that is relevant in the context of binding affinity. On average, our model accurately predicts binding affinity values for several protein-ligand complexes and exhibits higher accuracy for hydrolase, lyase, and families of proteins involved in mediating protein-protein interactions. Additionally, the Intergraph method displayed sensitivity to the binding mode when compared to a set of complexes that had undergone redocking calculations

SAGERank: Inductive Learning of Protein-Protein Interaction from Antibody-Antigen Recognition Using Graph Sample and Aggregate Networks Framework

InteractionGraphNet: A Novel and Efficient Deep Graph Representation Learning Framework for Accurate Protein–Ligand Interaction Predictions

Towards the accurate modelling of antibody-antigen complexes from sequence using machine learning and information-driven docking

A new paradigm for applying deep learning to protein–ligand interaction prediction

Deep Geometric Framework to Predict Antibody-Antigen Binding Affinity

AI-Augmented Physics-Based Docking for Antibody-Antigen Complex Prediction

GAABind: a Geometry-Aware Attention-Based Network for Accurate Protein-Ligand Binding Pose and Binding Affinity Prediction

TransfIGN: A Structure-Based Deep Learning Method for Modeling the Interaction between HLA-A*02:01 and Antigen Peptides

Striped-Cross Attention Network with Implicit Semantic Knowledge for Antibody Structure Prediction

GraphscoreDTA: Optimized Graph Neural Network for Protein–ligand Binding Affinity Prediction

Development and evaluation of a deep learning model for protein-ligand binding affinity prediction

Encoding Protein-Ligand Interactions: Binding Affinity Prediction with Multigraph-based Modeling and Graph Convolutional Network

Pretrainable Geometric Graph Neural Network for Antibody Affinity Maturation

Leveraging Scaffold Information to Predict Protein-Ligand Binding Affinity with an Empirical Graph Neural Network.

Benchmarking Inverse Folding Models for Antibody CDR Sequence Design

DEELIG: A Deep Learning Approach to Predict Protein-Ligand Binding Affinity

Benchmarking Generative Models for Antibody Design & Exploring Log-Likelihood for Sequence Ranking

ProBID-Net: A Deep Learning Model for Protein-Protein Binding Interface Design

Antibody Representation Learning for Drug Discovery

Interpretable antibody-antigen interaction prediction by introducing route and priors guidance